IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.

Polyethylene glycol (PEG)-modified bovine adenosine deaminase (ADA) is used for replacement therapy of severe combined immunodeficiency disease due to inherited ADA deficiency. We monitored IgG anti-ADA antibody in 17 patients treated by intramuscular injections of PEG-ADA for 1 to greater than 5.5...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	J Clin Invest
Hoofdauteurs:	Chaffee, S, Mary, A, Stiehm, E R, Girault, D, Fischer, A, Hershfield, M S
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	American Society for Clinical Investigation 1992
Onderwerpen:	Research Article
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC443041/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1569204/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115761
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!